How long is the life expectancy of patients with mid-stage renal cancer

Kidney cancer is one of the most common diseases in life. I believe we have all heard about people around us who died of kidney cancer. Kidney cancer is a serious tumor disease, and it is very harmful, especially in the middle stage of the disease, the patient's condition is even worse, which makes the patient lose confidence in the cure. So, how long can you live with kidney cancer in the middle stage? Let's take a look.

How long can you live with mid-stage kidney cancer?
Authoritative experts pointed out: It is difficult to have a clear answer to the question of how long patients with mid-stage renal cancer can live. The treatment of renal cancer is a systematic process involving many factors. In general, how long patients with mid-stage renal cancer can live, in other words, how long patients with mid-stage renal cancer can survive, mainly depends on whether the treatment method is appropriate and the patient's physical function. In addition, patients with mid-stage renal cancer and their families should learn more about the treatment knowledge of mid-stage renal cancer and communicate more with the attending physician, which will help prolong the survival period of mid-stage renal cancer. The main factors affecting how long patients with mid-stage renal cancer can live are the treatment method and the patient's physical condition. The 5-year survival rate after surgical resection of mid-stage renal cancer is relatively high.
The choice of treatment method for mid-stage renal cancer is an important factor affecting how long patients with mid-stage renal cancer can live. The main clinical treatment methods for mid-stage renal cancer include chemotherapy, radiotherapy, traditional Chinese medicine treatment, surgery, etc. Although traditional Chinese medicine can reduce the tumor to a certain extent in the treatment of mid-stage renal cancer, it will also increase toxic and side effects as the treatment time increases. Therefore, the drug and treatment time should be based on the tumor relief, symptom relief and treatment-related toxicity. Radiotherapy is also one of the most commonly used treatment methods for mid-stage renal cancer. It can shrink the tumor and improve symptoms. It is usually combined with chemotherapy, and the effect is better than radiotherapy alone or chemotherapy alone. However, radiotherapy and chemotherapy are more harmful to the body and should be used with caution in patients with mid-stage renal cancer who have poor physical function.